Clinical Trial Update: Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose, pharmacodynamics, and acceptability of a taste-optimized, low-volume polyethylene glycol bowel cleansing solution given in a spli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Polyethylene glycol electrolyte solution (low-volume bowel cleansing) (polyethylene glycol electrolyte solution)

Snippet

Sponsor: Norgine | Conditions: Colon Cancer | Phase 2 | Status: COMPLETED